Overview & Mechanism
Binds serum albumin via a drug affinity complex (DAC), extending half-life, and stimulates the GHRH receptor to increase baseline GH and IGF-1 over several days.
Research Dosage
1–2 mg/week (no DAC); 2 mg/week (DAC)
Subcutaneous injection
Once or twice weekly
8–12 weeks
Reconstitution & Storage
Reconstitute a 2 mg vial with 2 mL of bacteriostatic water (1 mg/mL).
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.
Safety & Side Effects
May cause water retention, joint discomfort, or tingling initially. DAC form has a longer half-life (weekly dosing).
Studies
CJC-1295 increases IGF-1 in healthy subjects
A single dose of CJC-1295 increased IGF-1 levels for up to 6 days in healthy adults, with a favorable safety profile.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.